Mechanisms of neuronal death in disease: Defining the models and the players

Biochemical Journal

Volumn 415, Issue 2, 2008, Pages 165-182

  Ribe, Elena M ^a   Serrano Saiz, Esther ^a   Akpan, Nsikan ^a   Troy, Carol M ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Alzheimer's disease; Bcl 2 family; Caspase; Cerebral ischaemia; Inhibitor of apoptosis protein (IAP); Stroke

Indexed keywords

CLARIFICATION;

ALZHEIMER'S DISEASE; BCL-2 FAMILY; CASPASE; CEREBRAL ISCHAEMIA; INHIBITOR OF APOPTOSIS PROTEIN (IAP); STROKE;

CELL DEATH;

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CHOLINESTERASE; GAMMA SECRETASE; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 1BETA CONVERTING ENZYME; PRESENILIN 1; PRESENILIN 2; PROTEIN BCL 2; PROTEIN BCL XL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; X LINKED INHIBITOR OF APOPTOSIS;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; HEREDITY; HUMAN; HYPOTHESIS; INCIDENCE; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CASPASES; HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEURONS; SIGNAL TRANSDUCTION;

EID: 54049138387     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20081118     Document Type: Review

References (203)

1. Ribe Garrido, E., Heidt, L., Beaubier, N. and Troy, C. M. (2008) Molecular mechanisms of neuronal death. Handb. Neurochem. Mol. Neurobiol., in the press
2. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A. and Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660
3. Thornberry, N. A.. Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller. D. K., Molineaux, S. M., Weidner, J. R., Aunins, J. et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768-774
4. Yuan, J., Shaham, S., Ledoux, S.. Ellis, H. M. and Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652
5. Eckhart, L., Ban, J., Fischer. H. and Tschachler, E. (2000) Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation. Biochem. Biophys. Res. Commun. 277, 655-659
6. Fischer, H., Koenig, U., Eckhart, L. and Tschachler, E. (2002) Human caspase 12 has acquired deleterious mutations. Biochem. Biophys. Res. Commun. 293, 722-726
7. Roy, S., Sharom, J. R., Houde. C., Loisel, T. P., Vaillancourt, J. P., Shao, W., Saleh, M. and Nicholson, D. W. (2008) Confinement of caspase-12 proteolytic activity to autoprocessing. Proc. Natl. Acad. Sci. U.S.A. 105, 4133-4138
8. Boatright, K. M. and Salvesen, G. S. (2003) Caspase activation. Biochem. Soc. Symp. 70, 233-242
9. Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R. and Salvesen, G. S. (2003) A unified model for apical caspase activation. Mol. Cell 11, 529-541
10. Adams, J. M. and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337
11. Baliga, B. C., Read, S. H. and Kumar, S. (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ. 11, 1234-1241
12. Riedl, S. J. and Salvesen. G. S. (2007) The apoptosome: signalling platform of cell death. Nat. Rev. 8, 405-413
13. Denault, J. B., Eckelman, B. P., Shin, H., Pop, C. and Salvesen, G. S. (2007) Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem. J. 405, 11-19
14. Tinel, A. and Tschopp J. (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304, 843-846
15. Ribe, E. and Troy, C. M. (2007) Activation of caspase-2 in neuronal death: functional implications for Alzheimer's Disease. Neuroscience 2007 Meeting. San Diego, CA, U.S.A., 3-7 November 2007, Abstract J22
16. Berube, C., Boucher, L. M., Ma, W., Wakeham, A., Salmena, L., Hakem, R., Yeh, W. C., Mak, T. W. and Benchimol, S. (2005) Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc. Natl. Acad. Sci. U.S.A. 102, 14314-14320
17. Tinel, A., Janssens, S., Lippens. S., Cuenin, S., Logette, E., Jaccard, B., Quadroni, M. and Tschopp, J. (2007) Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-κ B pathway. EMBO J. 26, 197-208
18. Cuenin, S., Tinel, A., Janssens, S. and Tschopp, J. (2008) p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-κB and caspase-2 in response to genotoxic stress. Oncogene 27, 387-396
19. Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. and Dixit, V. M. (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930
20. Wang, L., Du, F. and Wang, X. (2008) TNF-α induces two distinct caspase-8 activation pathways. Cell 133, 693-703
21. Jia, S. H., Parodo, J., Kapus, A., Rotstein, O. D. and Marshall, J. C. (2008) Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8. J. Biol. Chem. 283, 5402-5413
22. Srinivasula, S. M. and Ashwell, J. D. (2008) IAPs: what's in a name? Mol. Cell 30, 123-135
23. Eckelman, B. P., Salvesen, G. S. and Scott, F. L. (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988-994
24. Eckelman, B. P. and Salvesen, G. S. (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281, 3254-3260
25. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schroter, M., Burns, K., Mattmann, C. et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195
26. Du, C., Fang, M., Li, Y., Li, L. and Wang, X, (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42
27. Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J. and Vaux, D. L. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53
28. Hegde, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T. and Alnemri, E. S. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277, 432-438
29. Liston, P., Fong, W. G., Kelly, N. L.. Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W. and Korneluk, R. G. (2001) Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat. Cell Biol. 3, 128-133
30. Arora, V., Cheung, H. H., Plenchette, S., Micali, O. C., Liston, P. and Korneluk, R. G. (2007) Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J. Biol. Chem. 282, 26202-26209
31. Bonzon. C., Bouchier-Hayes, L., Pagliari, L. J., Green, D. R. and Newmeyer, D. D. (2006) Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol. Biol. Cell 17, 2150-2157
32. Chang, D. W., Xing, Z., Capacio, V. L., Peter, M. E. and Yang, X. (2003) Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22, 4132-4142
33. Pop, C., Fitzgerald, P., Green. D. R. and Salvesen, G. S. (2007) Role of proteolysis in caspase-8 activation and stabilization. Biochemistry 46, 4398-4407
34. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A.. Roy, S., Vaillancourt, J. P. et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911
35. Talanian. R. V., Quinlan, C., Trautz, S., Hackett, M. C., Mankovich, J. A., Banach, D., Ghayur, T., Brady. K. D. and Wong, W. W. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682
36. McStay, G. P., Salvesen, G. S. and Green, D. R. (2008) Overlapping cleavage motit selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 15, 322-331
37. Tu, S.. McStay, G. P., Boucher, L. M., Mak, T., Beere, H. M. and Green, D. R. (2006) In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis. Nat. Cell Biol. 8, 72-77
38. Turner, R. S. (2006) Alzheimer's disease. Semin. Neurol. 26, 499-506
39. Pappolla, M. A., Chyan, Y. J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J. and Reiter, R. J. (2000) An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm. 107, 203-231
40. Blennow, K., de Leon, M. J. and Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403
41. Small, G. W., Rabins, P. V.. Barry, P. P., Buckholtz, N. S., DeKosky, S. T., Ferris, S. H., Finkel, S. I., Gwyther, L. P. Khachaturian, Z. S., Lebowitz, B. D. et al. (1997) Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA, J. Am. Med. Assoc. 278, 1363-1371
42. Terry, R. D., Peck, A., DeTeresa, R., Schechter, R. and Horoupian, D. S. (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192
43. Scott, S. A., DeKosky, S. T., Sparks, D. L., Knox, C. A. and Scheff, S. W. (1992) Amygdala cell loss and atrophy in Alzheimer's disease. Ann. Neurol. 32, 555-563
44. Khachaturian, Z. S. (2000) Toward a comprehensive theory of Alzheimer's disease: challenges, caveats, and parameters. Ann. N. Y. Acad. Sci. 924, 184-193
45. Khachaturian, Z. S. (2000) Neurobiology of aging: Alzheimer's clinical review series. Bridging bench to bedside: clinical problems in search of basic solution. Neurobiol. Aging 21, 843
46. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R. and Van Hoesen, G. W. (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116
47. Braak, H. and Braak, E. (1991) Demonstration of amylold deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1, 213-216
48. Braak, H. and Braak, E. (1991) Morphological changes in the human cerebral cortex in dementia. J. Hirnforsch. 32, 277-282
49. Arriagada, P. V., Marzloff, K. and Hyman, B. T. (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681-1688
50. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. and Hyman, B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639
51. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766
52. Goate, A., Chartier-Harlin, M. C., M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706
53. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760
54. Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A., Weber, J. L., Bird, T. D. and Schellenberg, G. D. (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973
55. Kowalska, A., Pruchnik-Wolinska, D., Florczalk, J., Modestowicz, R., Szczech, J., Kozubski, W., Rossa, G. and Wender, M. (2004) Genetic study of familial cases of Alzheimer's disease. Acta Biochim. Pol. 51, 245-252
56. Kowalska, A., Pruchnik-Wolinska, D., Florczak, J., Szczech, J., Kozubsi W., Rossa, G. and Wender, M. (2004) Presenilin 1 mutations in Polish families with early-onset Alzheimer's disease. Folia Neuropathol. 42, 9-14
57. Lusis, A. J., Heinzmann, C., Sparkes, R. S., Scott, J., Knott, T. J., Geller, R., Sparkes, M. C. and Mohandas, T. (1986) Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI. Proc. Natl. Acad. Sci. U.S.A. 83, 3929-3933
58. Corder, E. H., Saunders, A. M.. Strittmatter. W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
59. Ma, J., Yee. A., Brewer, Jr, H. B., Das, S. and Potter, H. (1994) Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94
60. Das, S. and Potter, H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456
61. Mattila, K. M., Rinne, J. O., Roytta, M., Laippala, P., Pietila, T., Kalimo, H., Koivula, T., Frey, H. and Lehtimaki, T. (2000) Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E ε4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. J. Med. Genet. 37, 766-770
62. Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Baker, M., Adamson, J., Ronald. J., Blangero, J., Hutton, M. and Younkin, S. G. (2000) Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290, 2303-2304
63. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens. J., Donaldson, T., Gillespie. F. et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527
64. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D. et al. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218
65. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102
66. Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H.. Games. D. et al. (1997) Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1550-1555
67. Sturchler-Pierrat. C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl. C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A. et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292
68. Terai, K., Iwai, A., Kawabata. S., Tasaki, Y., Watanabe, T., Miyata, K. and Yamaguchi, T. (2001) β-Amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104, 299-310
69. Callahan, M. J., Lipinski, W. J., Bian, F. Durham, R. A., Pack, A. and Walker, L. C. (2001) Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice. Am. J. Pathol. 158, 1173-1177
70. Gotz, J., Probst, A., Spillantini, M. G., Schafer. T., Jakes, R., Burki, K. and Goedert, M. (1995) Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 14, 1304-1313
71. Gotz, J., Chen, F., Barmettler, R. and Nitsch, R. M. (2001) Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534
72. Brion, J. P., Tremp, G. and Octave, J. N. (1999) Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 154, 255-270
73. Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A. et al. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153-2165
74. Probst, A., Gotz, J., Wiederhold, K. H., Tolnay, M., Mistl, C., Jaton, A. L., Hong, M., Ishihara, T., Lee, V. M., Trojanowski, J. Q. et al. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99, 469-481
75. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M.. Yu, X. et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405
76. Tanemura, K., Akagi, T., Murayama. M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J. M.. Matsuda, K., Nakao, S. et al. (2001) Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol. Dis. 8, 1036-1045
77. Tanemura, K., Murayama, M., Akagi, T., Hashikawa, T., Tominaga, T., Ichikawa, M., Yamaguchi, H. and Takashima, A. (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J. Neurosci. 22, 133-141
78. Lim, F., Hernandez, F, Lucas, J. J., Gomez-Ramos, P., Moran, M. A. and Avila, J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell, Neurosci. 18, 702-714
79. Tatebayashi, Y., Miyasaka, T., Chui, D. H., Akagi, T., Mishima, K.. Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama. M.. Ishiguro, K. et al. (2002) Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl. Acad. Sci. U.S.A. 99, 13896-13901
80. Gotz, J., Chen, F, van Dorpe, J. and Nitsch, R. M. (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Aβ42 fibrils. Science 293, 1491-1495
81. De Jonghe, C., Esselens, C., Kumar-Singh, S., Craessaerts, K., Serneels, S., Checler, F., Annaert, W., Van Broeckhoven, C. and De Strooper, B. (2001) Pathogenic APP mutations near the γ-secretase cleavage site differentially affect Aβ secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 1665-1671
82. Golde, T. E. and Janus, C. (2005) Homing in on intracellular Aβ? Neuron 45, 639-642
83. Golde, T. E. (2005) The Aβ hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 15, 84-87
84. Kowalska, A. (2004) Genetic aspects of amyloid p-protein fibrillogenesis in Alzheimer's disease. Folia Neuropathol. 42, 235-237
85. Theuns, J., Marjaux, E., Vandenbulcke, M., Van Laere, K., Kumar-Singh, S., Bormans, G., Brouwers, N., Van den Broeck, M,, Vennelkens, K., Corsmit, E. et al. (2006) Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Hum. Mutat. 27, 888-896
86. Theuns, J., Brouwers, N., Engelborghs, S., Sleegers, K., Bogaerts, V., Corsmit, E., De Pooter, T., van Duijn, C. M., De Deyn. R P. and Van Broeckhoven, C. (2006) Promoter mutations that increase annyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 78, 936-946
87. Walker, E. S., Martinez, M., Brunkan, A. L. and Goate, A. (2005) Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Aβ 42/40 ratios. J. Neurochem. 92, 294-301
88. Duyckaerts, C., Potier, M. C. and Delatour, B. (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115, 5-38
89. Lambert, M. R, Barlow, A, K., Chromy, B. A., Edwards, c., Freed, R., Liosatos, M., Morgan, I E.. Rozovsky, I., Trommer, B., Viola, K. L. et al. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
90. Wang, H. W., Pasternak, J. F, Kuo, H., Ristic, H., Lambert. M. R, Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B.. Krafff, G. A. and Trommer, B. L. (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924, 133-140
91. Walsh, D. M., Tseng, B. R, Rydel, R. E., Podlisny, M. B. and Selkoe, D. J. (2000) The oligonnerization of annyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831-10839
92. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Rowan, M. J. and Selkoe, D. J. (2002) Amyloid-β oligomers: their production. toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30: 552-557
93. Barghorn, S., Nimmrich. V., Striebinger, A., Krantz, C., Keller, P, Janson, B.. Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J. et al. (2005) Globular annyloid β-peptide oligomer: a homogenous and stable neufopathologiral protein in Alzheimer's disease. J. Neurochem. 95, 834-847
94. Lesne, S., Koh, M. T., Kotilinek, L.. Kayed, R., Glabe, C. G., Yang, A., Gallagher. M. and Ashe, K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357
95. Nimmrich, V, Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U. and Bruehl, C. (2008) Amyloid β oligomers (Aβ(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J. Neurosci, 28, 788-797
96. McPhie, D. L., Golde, T., Eckman, C. B., Yager, D., Brant, J. B. and Neve, R. L. (2001) β-Secretase cleavage of the annyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Mol. Brain Res. 97, 103-113
97. Koo, E. H. (2002) The β-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic 3, 763-770
98. Zheng, H. and Koo, E. H. (2006) The amyloid precursor protein: beyond amyloid. Mol. Neurodegener. 1, 5
99. Lu, D. C., Rabizadeh, S.. Chandra, S., Shayya, R. F., Ellerby, L. M.. Ye, X., Salvesen, G. S.. Koo, E. H. and Bredesen, D. E. (2000) A second cytotoxic proteolytic peptide derived from annyloid β-protein precursor Nat. Med. 6, 397-404
100. 664. Behav. Brain Res. 191, 246-255
101. Cotman, C. W. and Anderson, A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45
102. Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S. et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 97, 395-406
103. Pompl, P. N., Yemul, S., Xiang, Z., Ho, L., Haroutunian, V., Purohit, D., Mohs, R. and Pasinetti, G. M. (2003) Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 60, 369-376
104. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C. and Hammond, J. (1999) Caspase-6 role in apoptosis of human neurons. amyloidogenesis, and Alzheimer's disease. J. Biol. Chem. 274, 23426-23436
105. Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Bruck, W., Jellinger, K. and Lassmann, H. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death. Am. J. Pathol. 155, 1459-1466
106. Pellegrini, L., Passer, B. J., Tabaton, M., Ganjei, J. K. and D'Adamio, L. (1999) Alternative, non-secretase processing of Alzheimer's β-amyloid precursor protein during apoptosis by caspase-6 and -8. J. Biol. Chem. 274, 21011-21016
107. Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar. S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N. et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 10032-10037
108. Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T. and Cotman, C. W. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114, 121-130
109. Troy, C. M., Rabacchi, S. A.. Friedman, W. J., Frappier, T. F., Brown, K. and Shelanski, M. L. (2000) Caspase-2 mediates neuronal cell death induced by β-amyloid. J. Neurosci. 20, 1386-1392
110. Nakagawa, T., Zhu, H., Morishima, M., Li, E., Xu, J,, Yankner, B. A. and Yuan, J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98-103
111. Saleh, M., Vaillancourt, J, P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S. et al. (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75-79
112. Reed, J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6
113. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. and Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132
114. Kluck, R. M., Bossy-Wetzel, F., Green, D. R. and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136
115. Alberici, A., Moratto, D., Benussi, L., Gasparini, L., Ghidoni, R., Gatta, L. B., Finazzi, D., Frisoni, G. B., Trabucchi, M., Growdon, J. H. et al, (1999) Presenilin 1 protein directly interacts with Bcl-2. J. Biol. Chem. 274, 30764-30769
116. Shinozaki, K., Maruyama, K., Kume, H., Tomita, T., Saido, T C., Iwatsubo, T. and Obata, K. (1998) The presenilin 2 loop domain interacts with the μ-calpain C-terminal region. Int. J. Mol. Med. 1, 797-799
117. Buxbaum, J. D., Choi, E. K., Luo, Y., Lilliehook, C., Crowley, A. C., Merriam, D. E. and Wasco, W. (1998) Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4, 1177-1181
118. Keller, J. N., Guo, Q., Holtsberg, F. W., Bruce-Keller, A. J. and Mattson, M. P. (1998) Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18, 4439-4450
119. L: a potential role in modulating the threshold of cell death. J. Biol. Chem. 274, 24007-24013
120. Lu, G., Kwong, W. H., Li, Q., Wang, X., Feng, Z. and Yew, D. T. (2005) bcl2, bax, and nestin in the brains of patients with neurodegeneration and those of normal aging. J. Mol. Neurosci. 27, 167-174
121. Rohn, T. T., Vyas, V., Hernandez-Estrada, T., Nichol, K. E., Christie, L. A. and Head, E. (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J. Neurosci. 28, 3051-3059
122. Yao, M., Nguyen, T. V. and Pike, O. J. (2005) β-Amyloid-induced neuronal apootosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J. Neurosci. 25, 1149-1158
123. Karlnoski, R., Wilcock, D., Dickey, C., Ronan, V., Gordon, M. N., Zhang, W., Morgan, D. and Taglialatela, G. (2007) Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection. Neurobiol. Dis. 25, 179-188
124. Biswas, S. C., Shi, Y., Vonsattel, J. P., Leung. C. L., Troy, C. M. and Greene, L. A. (2007) Bim is elevated in Alzheimer's disease neurons and is required for β-amyloid-induced neuronal apoptosis. J. Neurosci. 27, 893-900
125. Warlow, C. P. (1998) Epidemiology of stroke. Lancet 352, (Suppl 3), SIII1-SIII4
126. del Zoppo G. J. (2006) Stroke and neurovascular protection. N. Engl. J. Med. 354, 553-555
127. Lo, E. H., Dalkara, T. and Moskowitz, M. A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415
128. Garcia, J. H., Liu, K. F. and Ho, K. L. (1995) Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26, 636-642
129. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568
130. Linnik, M. D., Zobrist. R. H. and Hatfield. M. D. (1993) Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008
131. Charriaut-Marlangue, C., Margaill, I., Represa, A., Poi T., Plotkine, M. and Ben-Ari, Y. (1996) Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J. Cereb. Blood Flow Metab. 16, 186-194
132. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L.. Johnston. C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J. et al. (1995) Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401-411
133. Benchoua, A., Guegan, C., Couriaud, C., Hosseini, i Sampaio, N., Morin, D. and Onteniente, B. (2001) Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 21, 7127-7134
134. Kerr, J. F., Wyllie, A. H. and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257
135. Mattson, M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129
136. Love, S. (2003) Apoptosis and brain ischaemia. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 267-282
137. Ferrer, I. (2006) Apoptosis: future targets for neuroprotective strategies. Cerebrovasc. Dis. 21, (Suppl. 2). 9-20
138. Martin, L. J., Al-Abdulla, N. A., Brambrink, A. M., Kirsch, J. R., Sieber, F. E. and Portera-Cailliau, C. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281-309
139. Leist, M. and Jaattela, M. (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589-598
140. Zeng, Y. S. and Xu, Z. C. (2000) Co-existence of necrosis and apoptosis in rat hippocampus following transient forebrain ischemia. Neurosci. Res. 37, 113-125
141. Choi, D. W. (1996) Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6, 667-672
142. Gwag, B, J., Lobner, D., Koh. J. Y., Wie, M. B. and Choi, D. W. (1995) Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 68, 615-619
143. Pan, J., Konstas, A. A., Bateman, B., Ortolano, G. A. and Pile-Spellman, J. (2007) Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 49, 93-102
144. Kahles, T., Luedike. P., Endres, M., Galla, H. J., Steinmetz, H., Busse, R., Neumann-Haefelin, T. and Brandes, R. P. (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38, 3000-3006
145. Traystman, R. J. (2003) Animal models of focal and global cerebral ischemia. ILAR J. 44, 85-95
146. Richard Green, A., Odergren, T. and Ashwood, T. (2003) Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol. Sci. 24, 402-408
147. Dronne, M. A., Grenier, E., Chapuisat, G., Hommel, M. and Boissel, J. P. (2008) A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients. Prog. Biophys. Mol. Biol. 97, 28-39
148. Rothman, S. M. (1983) Synaptic activity mediates death of hypoxic neurons. Science 220, 536-537
149. Goldberg, M. P. and Choi, D. W. (1993) Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium- independent mechanisms of neuronal injury. J. Neurosci. 13, 3510-3524
150. Noraberg, J., Poulsen, F. R., Blaablerg, M., Kristensen, B. W., Bonde, C., Montero, M., Meyer, M., Gramsbergen, J. B. and Zimmer, J. (2005) Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets CNS Neurol. Disord. 4, 435-452
151. Goldberg, M. P., Monyer, H., Weiss, J. H. and Choi, D. W. (1988) Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci. Lett. 89, 323-327
152. Goldberg, M. P., Weiss, J. H., Pham, P. C. and Choi, D. W. (1987) N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J. Pharmacol. Exp. Ther. 243, 784-791
153. Moroni, F., Meli, E., Peruginelli, F., Chiarugi, A., Cozzi, A., Picca, R., Romagnoli, P., Pellicciari, R. and Pellegrini-Giampietro, D. E. (2001) Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ. 8, 921-932
154. Laake, J. H., Haug, F. M., Wieloch, T. and Ottersen, O. P. (1999) A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence, Brain Res. Protoc. 4, 173-184
155. Frantseva, M. V., Carlen, P. L. and El-Beheiry, H. (1999) A submersion method to induce hypoxic damage in organotypic hippocampal cultures. J. Neurosci. Methods 89, 25-31
156. Schurr, A., Payne, R. S., Miller, J. J. and Rigor, B. M. (1999) Study of cerebral energy metabolism using the rat hippocampal slice preparation. Methods 18, 117-126
157. Schurr, A., Tseng, M. T., West, C. A. and Rigor, B. M. (1987) Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci. 40, 2059-2066
158. Calabresi, P., Centonze, D. and Bernardi, G. (2000) Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology 55, 1249-1255
159. Pedersen, J. Z., Bernardi, G., Centonze, D,, Pisani, A., Rossi, L., Rotilio, G. and Calabresi, P. (1998) Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation. J. Cereb. Blood Flow Metab, 18, 868-875
160. Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374
161. Choi, D. W. and Rothman, S. M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182
162. Simon, R. P., Swan, J. H., Griffiths, T. and Meldrum, B. S. (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852
163. Meli, E., Pangallo, M., Baronti, R., Chiarugi, A., Cozzi, A., Pellegrini-Giampietro, D. E. and Moroni, F. (2003) Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage. Toxicol. Lett. 139, 153-162
164. Ray, A. M., Owen, D. E.. Evans, M. L., Davis, J. B. and Benham, C. D. (2000) Caspase inhibitors are functionally neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slices. Brain Res. 867, 62-69
165. Gottron, F. J., Ying, H. S. and Choi, D. W. (1997) Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell. Neurosci. 9, 159-169
166. Malagelada, C., Xifro, X., Minano, A., Sabria, J. and Rodriguez-Alvarez, J. (2005) Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures. Neurobiol. Dis. 20, 27-37
167. Taranukhin, A. G., Taranukhina, E. Y., Saransaari, P., Djatchkova, I. M., Pelto-Huikko, M. and Oja, S. S. (2008) Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei. Amino Acids 34, 169-174
168. Le, D. A., Wu, Y., Huang, Z., Matsushita, K., Plesnila, N., Augustinack, J. C.. Hyman, B. T., Yuan, J., Kuida, K., Flavell, R. A. and Moskowitz, M. A. (2002) Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. U.S.A. 99, 15188-15193
169. Troy, C. M., Derossi, D., Prochiantz, A., Greene, L. A. and Shelanski, M. L. (1996) Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16, 253-261
170. Davidson, T. J., Harel, S., Arboleda, V. A., Prunell, G. F., Shelanski, M. L., Greene. L. A. and Troy, C. M. (2004) Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation. J. Neurosci. 24, 10040-10046
171. Fujimura, M., Morita-Fujimura, Y., Noshita, N., Sugawara, T., Kawase, M. and Chan, P. H. (2000) The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 20, 2817-2824
172. Kondo, T., Reaume, A. G., Huang, T. T., Carlson, E., Murakami, K., Chen, S. F., Hoffman, E. K., Scott, R. W., Epstein, C. J. and Chan, P. H. (1997) Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17, 4180-4189
173. Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y. and Rothwell, N. J. (2001) Role of IL-1α and IL-1β in ischemic brain damage. J. Neurosci. 21, 5528-5534
174. Bothwell, N. (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152-157
175. Friedlander, R. M., Gagliardini, V., Hara, H., Fink, K. B., Li, W., MacDonald, G., Fishman, M. C., Greenberg, A. H.. Moskowitz, M. A. and Yuan, J. (1997) Expression of a dominant negative mutant of interleukin-1 β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185, 933-940
176. Schielke, G. P., Yang, G. Y. Shivers, B. D. and Betz, A. L. (1998) Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice, J. Cereb. Blood Flow Metab. 18, 180-185
177. Allan. S. M., Tyrrell, P. J. and Rothwell, N. J. (2005) Interleukin-1 and neuronal injury. Nat. Bev. Immunol. 5, 629-640
178. Thornton, P., Pinteaux, E., Gibson, R. M.. Allan, S. M. and Bothwell, N. J. (2006) Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J. Neurochem. 98, 258-266
179. Namura, S., Zhu, J., Fink, K., Endres. M,, Srinivasan, A., Tomaselli, K. J,. Yuan, J. and Moskowitz, M. A. (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659-3668
180. Velier, J. J., Ellison, J. A., Kikly. K. K., Spera, P. A., Barone, F. C. and Feuerstein, G. Z. (1999) Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J. Neurosci. 19, 5932-5941
181. Guegan, C. and Sola, B. (2000) Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res. 856, 93-100
182. Love, S., Barber, R., Srinivasan, A. and Wilcock, G. K. (2000) Activation of caspase-3 in permanent and transient brain ischaemia in man. NeuroReport 11, 2495-2499
183. Harrison, D. C., Davis, R. P., Bond, B. C., Campbell. C. A., James, M. F., Parsons, A. A. and Philpott, K. L. (2001) Caspase mRNA expression in a rat model of focal cerebral ischemia. Mol. Brain Res. 89, 133-146
184. Ferrer, I. and Planas, A. M. (2003) Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 62, 329-339
185. Trapp, T., Korhonen, L., Besselmann, M.. Martinez, R., Mercer, E. A. and Lindholm, D. (2003) Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol. Cell. Neurosci. 23, 302-313
186. Saito, A., Hayashi, T., Okuno, S., Ferrand-Drake, M. and Chan, P. H. (2003) Interaction between XIAP and Smac/DIABLO in the mouse brain after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23, 1010-1019
187. Saito, A.. Hayashi, T., Okuno, S., Nishi, T. and Chan, P. H. (2004) Oxidative stress is associated with XIAP and Smac/DIABLO signaling pathways in mouse brains after transient focal cerebral ischemia. Stroke 35, 1443-1448
188. Xu, D., Bureau, Y., McIntyre, D. C,, Nicholson, D. W., Liston, P., Zhu, Y., Fong, W. G., Crocker, S. J., Korneluk, R. G. and Robertson, G. S. (1999) Attenuation of ischemia-induced cellular and behavioral deficits by X Chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 19, 5026-5033
189. Tanaka, H., Yokota, H., Jover, T., Cappuccio, I., Calderone, A., Simionescu, M., Bennett, M, V. and Zukin, R. S. (2004) Ischemic preconditioning: neuronal survival in the face of caspase-3 activation. J. Neurosci. 24, 2750-2759
190. Zhao, H., Yenari, M. A., Sapolsky, R. M. and Steinberg, G. K. (2004) Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome c release. Stroke 35, 572-577
191. Antonawich, F. J., Federoff, H. J. and Davis, J. N. (1999) BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia. Exp. Neurol. 156, 130-137
192. Zhao, H., Yenari, M. A., Cheng. D., Sapolsky, R. M. and Steinberg, G. K. (2003) Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85, 1026-1036
193. Linnik, M. D., Zahos, P., Geschwind, M. D. and Federoff, H. J. (1995) Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischernia. Stroke 26, 1670-1674
194. Cao, G., Minami, M., Pei, W., Yan, C., Chen, D., O'Horo, C., Graham, S. H. and Chen, J. (2001) Intracellular Bax translocation after transient cerebral lschemia: implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. J. Cereb. Blood Flow Metab. 21, 321-333
195. Plesnila, N., Zinkel, S., Le, D. A., Amin-Hanjani, S., Wu, Y., Qiu, J., Chiarugi, A., Thomas, S. S., Kohane, D. S., Korsmeyer, S. J. and Moskowitz, M. A. (2001) BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 98, 15318-15323
196. Yin, X. M., Luo, Y., Cao, G., Bai, L., Pei, W., Kuharsky, D. K. and Chen, J. (2002) Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia. J. Biol. Chem. 277, 42074-42081
197. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde. T. E., Kayed, R., Metherate, R., Mattson, M. R. Akbari, Y. and LaFerla, F. M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421
198. Ribe, E. M., Perez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S. Sanchez, B., Nielo, M. et al. (2005) Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis. 20, 814-822
199. Hitomi, J., Katayama, T., Eguchi, Y., Kudo, T., Taniguchi, M., Koyama, Y., Manabe, T., Yamagishi, S., Bando, Y., Imaizumi, K., Tsujimoto, Y. and Tohyama, M. (2004) Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J. Cell Biol. 165, 347-356
200. Friedlander, R. M., Brown, R. H., Gagliardini, V., Wang, J. and Yuan, J. (1997) Inhibition of ICE slows ALS in mice. Nature 388, 31
201. Erratum (1998) Nature 392, 560
202. Krajewski, S., Krajewska, M., Ellerby, L. M.. Welsh, K., Xie, Z., Deveraux, Q. L., Salvesen, G. S., Bredesen, D. E.. Rosenthal, R. E.. Fiskum, G. and Reed, J. C. (1999) Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 96, 5752-5757
203. Kang, S. J., Wang, S., Hara, H., Peterson, E. P., Namura, S., Amin-Hanjani, S., Huang, Z., Srinivasan, A., Tomaselli, K. J., Thornberry, N. A. et al. (2000) Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149, 613-622